Neuronetics Total Operating Expenses from 2010 to 2026
| STIM Stock | USD 1.56 0.14 9.86% |
Total Operating Expenses | First Reported 2016-03-31 | Previous Quarter 25.8 M | Current Value 24.4 M | Quarterly Volatility 7.7 M |
Check Neuronetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuronetics' main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.3 M or Interest Expense of 4.4 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or PTB Ratio of 1.89. Neuronetics financial statements analysis is a perfect complement when working with Neuronetics Valuation or Volatility modules.
Neuronetics | Total Operating Expenses | Build AI portfolio with Neuronetics Stock |
Evaluating Neuronetics's Total Operating Expenses across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Neuronetics's fundamental strength.
Latest Neuronetics' Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Neuronetics over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Neuronetics' Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuronetics' overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Neuronetics Total Operating Expenses Regression Statistics
| Arithmetic Mean | 58,830,069 | |
| Geometric Mean | 54,868,539 | |
| Coefficient Of Variation | 38.39 | |
| Mean Deviation | 19,721,241 | |
| Median | 59,999,000 | |
| Standard Deviation | 22,582,598 | |
| Sample Variance | 510T | |
| Range | 65.1M | |
| R-Value | 0.91 | |
| Mean Square Error | 95.3T | |
| R-Squared | 0.82 | |
| Slope | 4,061,298 | |
| Total Sum of Squares | 8159.6T |
Neuronetics Total Operating Expenses History
About Neuronetics Financial Statements
Neuronetics investors utilize fundamental indicators, such as Total Operating Expenses, to predict how Neuronetics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 102 M | 73.7 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Neuronetics Correlation against competitors. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.